 | • レポートコード：MRC2Q12-16783 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、体外診断用抗体のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 体外診断用抗体のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 体外診断用抗体の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 体外診断用抗体のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの体外診断用抗体の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の体外診断用抗体の売上および2028年までの予測に焦点を当てています。 体外診断用抗体のグローバル主要企業には、Creative Biolabs、GenScript、PROGEN、apDia、Bio-Techne、Rockland、Leadgene Biomedical、MBL Life Science、Alpha Diagnostic、Rekom Biotech SL、Diasource、ImmunoReagents、Rapid Novorなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 体外診断用抗体市場は、タイプとアプリケーションによって区分されます。世界の体外診断用抗体市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 生化学試薬診断、免疫試薬診断 【アプリケーション別セグメント】 病院、診断センター 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 体外診断用抗体製品概要 - タイプ別市場（生化学試薬診断、免疫試薬診断） - アプリケーション別市場（病院、診断センター） - 調査の目的 ・エグゼクティブサマリー - 世界の体外診断用抗体販売量予測2017-2028 - 世界の体外診断用抗体売上予測2017-2028 - 体外診断用抗体の地域別販売量 - 体外診断用抗体の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別体外診断用抗体販売量 - 主要メーカー別体外診断用抗体売上 - 主要メーカー別体外診断用抗体価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（生化学試薬診断、免疫試薬診断） - 体外診断用抗体のタイプ別販売量 - 体外診断用抗体のタイプ別売上 - 体外診断用抗体のタイプ別価格 ・アプリケーション別市場規模（病院、診断センター） - 体外診断用抗体のアプリケーション別販売量 - 体外診断用抗体のアプリケーション別売上 - 体外診断用抗体のアプリケーション別価格 ・北米市場 - 北米の体外診断用抗体市場規模（タイプ別、アプリケーション別） - 主要国別の体外診断用抗体市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの体外診断用抗体市場規模（タイプ別、アプリケーション別） - 主要国別の体外診断用抗体市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の体外診断用抗体市場規模（タイプ別、アプリケーション別） - 主要国別の体外診断用抗体市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の体外診断用抗体市場規模（タイプ別、アプリケーション別） - 主要国別の体外診断用抗体市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの体外診断用抗体市場規模（タイプ別、アプリケーション別） - 主要国別の体外診断用抗体市場規模（トルコ、サウジアラビア） ・企業情報 Creative Biolabs、GenScript、PROGEN、apDia、Bio-Techne、Rockland、Leadgene Biomedical、MBL Life Science、Alpha Diagnostic、Rekom Biotech SL、Diasource、ImmunoReagents、Rapid Novor ・産業チェーン及び販売チャネル分析 - 体外診断用抗体の産業チェーン分析 - 体外診断用抗体の原材料 - 体外診断用抗体の生産プロセス - 体外診断用抗体の販売及びマーケティング - 体外診断用抗体の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 体外診断用抗体の産業動向 - 体外診断用抗体のマーケットドライバー - 体外診断用抗体の課題 - 体外診断用抗体の阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for In Vitro Diagnostic Antibodies estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for In Vitro Diagnostic Antibodies is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for In Vitro Diagnostic Antibodies is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for In Vitro Diagnostic Antibodies is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of In Vitro Diagnostic Antibodies include Creative Biolabs, GenScript, PROGEN, apDia, Bio-Techne, Rockland, Leadgene Biomedical, MBL Life Science and Alpha Diagnostic, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the In Vitro Diagnostic Antibodies companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional In Vitro Diagnostic Antibodies market. Further, it explains the major drivers and regional dynamics of the global In Vitro Diagnostic Antibodies market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Creative Biolabs
GenScript
PROGEN
apDia
Bio-Techne
Rockland
Leadgene Biomedical
MBL Life Science
Alpha Diagnostic
Rekom Biotech SL
Diasource
ImmunoReagents
Rapid Novor
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
In Vitro Diagnostic Antibodies Segment by Type
Biochemical Reagent Diagnosis
Immunoreagent Diagnosis
In Vitro Diagnostic Antibodies Segment by Application
Hospital
Diagnostic Center
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the In Vitro Diagnostic Antibodies market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for In Vitro Diagnostic Antibodies market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of In Vitro Diagnostic Antibodies, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for In Vitro Diagnostic Antibodies, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the In Vitro Diagnostic Antibodies revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global In Vitro Diagnostic Antibodies market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for In Vitro Diagnostic Antibodies revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Creative Biolabs, GenScript, PROGEN, apDia, Bio-Techne, Rockland, Leadgene Biomedical, MBL Life Science and Alpha Diagnostic, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of In Vitro Diagnostic Antibodies in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of In Vitro Diagnostic Antibodies companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, In Vitro Diagnostic Antibodies revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In Vitro Diagnostic Antibodies Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Biochemical Reagent Diagnosis
1.2.3 Immunoreagent Diagnosis
1.3 Market by Application
1.3.1 Global In Vitro Diagnostic Antibodies Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Diagnostic Center
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global In Vitro Diagnostic Antibodies Market Perspective (2017-2028)
2.2 In Vitro Diagnostic Antibodies Growth Trends by Region
2.2.1 In Vitro Diagnostic Antibodies Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 In Vitro Diagnostic Antibodies Historic Market Size by Region (2017-2022)
2.2.3 In Vitro Diagnostic Antibodies Forecasted Market Size by Region (2023-2028)
2.3 In Vitro Diagnostic Antibodies Market Dynamics
2.3.1 In Vitro Diagnostic Antibodies Industry Trends
2.3.2 In Vitro Diagnostic Antibodies Market Drivers
2.3.3 In Vitro Diagnostic Antibodies Market Challenges
2.3.4 In Vitro Diagnostic Antibodies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In Vitro Diagnostic Antibodies Players by Revenue
3.1.1 Global Top In Vitro Diagnostic Antibodies Players by Revenue (2017-2022)
3.1.2 Global In Vitro Diagnostic Antibodies Revenue Market Share by Players (2017-2022)
3.2 Global In Vitro Diagnostic Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by In Vitro Diagnostic Antibodies Revenue
3.4 Global In Vitro Diagnostic Antibodies Market Concentration Ratio
3.4.1 Global In Vitro Diagnostic Antibodies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In Vitro Diagnostic Antibodies Revenue in 2021
3.5 In Vitro Diagnostic Antibodies Key Players Head office and Area Served
3.6 Key Players In Vitro Diagnostic Antibodies Product Solution and Service
3.7 Date of Enter into In Vitro Diagnostic Antibodies Market
3.8 Mergers & Acquisitions, Expansion Plans
4 In Vitro Diagnostic Antibodies Breakdown Data by Type
4.1 Global In Vitro Diagnostic Antibodies Historic Market Size by Type (2017-2022)
4.2 Global In Vitro Diagnostic Antibodies Forecasted Market Size by Type (2023-2028)
5 In Vitro Diagnostic Antibodies Breakdown Data by Application
5.1 Global In Vitro Diagnostic Antibodies Historic Market Size by Application (2017-2022)
5.2 Global In Vitro Diagnostic Antibodies Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America In Vitro Diagnostic Antibodies Market Size (2017-2028)
6.2 North America In Vitro Diagnostic Antibodies Market Size by Type
6.2.1 North America In Vitro Diagnostic Antibodies Market Size by Type (2017-2022)
6.2.2 North America In Vitro Diagnostic Antibodies Market Size by Type (2023-2028)
6.2.3 North America In Vitro Diagnostic Antibodies Market Share by Type (2017-2028)
6.3 North America In Vitro Diagnostic Antibodies Market Size by Application
6.3.1 North America In Vitro Diagnostic Antibodies Market Size by Application (2017-2022)
6.3.2 North America In Vitro Diagnostic Antibodies Market Size by Application (2023-2028)
6.3.3 North America In Vitro Diagnostic Antibodies Market Share by Application (2017-2028)
6.4 North America In Vitro Diagnostic Antibodies Market Size by Country
6.4.1 North America In Vitro Diagnostic Antibodies Market Size by Country (2017-2022)
6.4.2 North America In Vitro Diagnostic Antibodies Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe In Vitro Diagnostic Antibodies Market Size (2017-2028)
7.2 Europe In Vitro Diagnostic Antibodies Market Size by Type
7.2.1 Europe In Vitro Diagnostic Antibodies Market Size by Type (2017-2022)
7.2.2 Europe In Vitro Diagnostic Antibodies Market Size by Type (2023-2028)
7.2.3 Europe In Vitro Diagnostic Antibodies Market Share by Type (2017-2028)
7.3 Europe In Vitro Diagnostic Antibodies Market Size by Application
7.3.1 Europe In Vitro Diagnostic Antibodies Market Size by Application (2017-2022)
7.3.2 Europe In Vitro Diagnostic Antibodies Market Size by Application (2023-2028)
7.3.3 Europe In Vitro Diagnostic Antibodies Market Share by Application (2017-2028)
7.4 Europe In Vitro Diagnostic Antibodies Market Size by Country
7.4.1 Europe In Vitro Diagnostic Antibodies Market Size by Country (2017-2022)
7.4.2 Europe In Vitro Diagnostic Antibodies Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific In Vitro Diagnostic Antibodies Market Size (2017-2028)
8.2 Asia-Pacific In Vitro Diagnostic Antibodies Market Size by Type
8.2.1 Asia-Pacific In Vitro Diagnostic Antibodies Market Size by Type (2017-2022)
8.2.2 Asia-Pacific In Vitro Diagnostic Antibodies Market Size by Type (2023-2028)
8.2.3 Asia-Pacific In Vitro Diagnostic Antibodies Market Share by Type (2017-2028)
8.3 Asia-Pacific In Vitro Diagnostic Antibodies Market Size by Application
8.3.1 Asia-Pacific In Vitro Diagnostic Antibodies Market Size by Application (2017-2022)
8.3.2 Asia-Pacific In Vitro Diagnostic Antibodies Market Size by Application (2023-2028)
8.3.3 Asia-Pacific In Vitro Diagnostic Antibodies Market Share by Application (2017-2028)
8.4 Asia-Pacific In Vitro Diagnostic Antibodies Market Size by Region
8.4.1 Asia-Pacific In Vitro Diagnostic Antibodies Market Size by Region (2017-2022)
8.4.2 Asia-Pacific In Vitro Diagnostic Antibodies Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America In Vitro Diagnostic Antibodies Market Size (2017-2028)
9.2 Latin America In Vitro Diagnostic Antibodies Market Size by Type
9.2.1 Latin America In Vitro Diagnostic Antibodies Market Size by Type (2017-2022)
9.2.2 Latin America In Vitro Diagnostic Antibodies Market Size by Type (2023-2028)
9.2.3 Latin America In Vitro Diagnostic Antibodies Market Share by Type (2017-2028)
9.3 Latin America In Vitro Diagnostic Antibodies Market Size by Application
9.3.1 Latin America In Vitro Diagnostic Antibodies Market Size by Application (2017-2022)
9.3.2 Latin America In Vitro Diagnostic Antibodies Market Size by Application (2023-2028)
9.3.3 Latin America In Vitro Diagnostic Antibodies Market Share by Application (2017-2028)
9.4 Latin America In Vitro Diagnostic Antibodies Market Size by Country
9.4.1 Latin America In Vitro Diagnostic Antibodies Market Size by Country (2017-2022)
9.4.2 Latin America In Vitro Diagnostic Antibodies Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In Vitro Diagnostic Antibodies Market Size (2017-2028)
10.2 Middle East & Africa In Vitro Diagnostic Antibodies Market Size by Type
10.2.1 Middle East & Africa In Vitro Diagnostic Antibodies Market Size by Type (2017-2022)
10.2.2 Middle East & Africa In Vitro Diagnostic Antibodies Market Size by Type (2023-2028)
10.2.3 Middle East & Africa In Vitro Diagnostic Antibodies Market Share by Type (2017-2028)
10.3 Middle East & Africa In Vitro Diagnostic Antibodies Market Size by Application
10.3.1 Middle East & Africa In Vitro Diagnostic Antibodies Market Size by Application (2017-2022)
10.3.2 Middle East & Africa In Vitro Diagnostic Antibodies Market Size by Application (2023-2028)
10.3.3 Middle East & Africa In Vitro Diagnostic Antibodies Market Share by Application (2017-2028)
10.4 Middle East & Africa In Vitro Diagnostic Antibodies Market Size by Country
10.4.1 Middle East & Africa In Vitro Diagnostic Antibodies Market Size by Country (2017-2022)
10.4.2 Middle East & Africa In Vitro Diagnostic Antibodies Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Creative Biolabs
11.1.1 Creative Biolabs Company Details
11.1.2 Creative Biolabs Business Overview
11.1.3 Creative Biolabs In Vitro Diagnostic Antibodies Introduction
11.1.4 Creative Biolabs Revenue in In Vitro Diagnostic Antibodies Business (2017-2022)
11.1.5 Creative Biolabs Recent Developments
11.2 GenScript
11.2.1 GenScript Company Details
11.2.2 GenScript Business Overview
11.2.3 GenScript In Vitro Diagnostic Antibodies Introduction
11.2.4 GenScript Revenue in In Vitro Diagnostic Antibodies Business (2017-2022)
11.2.5 GenScript Recent Developments
11.3 PROGEN
11.3.1 PROGEN Company Details
11.3.2 PROGEN Business Overview
11.3.3 PROGEN In Vitro Diagnostic Antibodies Introduction
11.3.4 PROGEN Revenue in In Vitro Diagnostic Antibodies Business (2017-2022)
11.3.5 PROGEN Recent Developments
11.4 apDia
11.4.1 apDia Company Details
11.4.2 apDia Business Overview
11.4.3 apDia In Vitro Diagnostic Antibodies Introduction
11.4.4 apDia Revenue in In Vitro Diagnostic Antibodies Business (2017-2022)
11.4.5 apDia Recent Developments
11.5 Bio-Techne
11.5.1 Bio-Techne Company Details
11.5.2 Bio-Techne Business Overview
11.5.3 Bio-Techne In Vitro Diagnostic Antibodies Introduction
11.5.4 Bio-Techne Revenue in In Vitro Diagnostic Antibodies Business (2017-2022)
11.5.5 Bio-Techne Recent Developments
11.6 Rockland
11.6.1 Rockland Company Details
11.6.2 Rockland Business Overview
11.6.3 Rockland In Vitro Diagnostic Antibodies Introduction
11.6.4 Rockland Revenue in In Vitro Diagnostic Antibodies Business (2017-2022)
11.6.5 Rockland Recent Developments
11.7 Leadgene Biomedical
11.7.1 Leadgene Biomedical Company Details
11.7.2 Leadgene Biomedical Business Overview
11.7.3 Leadgene Biomedical In Vitro Diagnostic Antibodies Introduction
11.7.4 Leadgene Biomedical Revenue in In Vitro Diagnostic Antibodies Business (2017-2022)
11.7.5 Leadgene Biomedical Recent Developments
11.8 MBL Life Science
11.8.1 MBL Life Science Company Details
11.8.2 MBL Life Science Business Overview
11.8.3 MBL Life Science In Vitro Diagnostic Antibodies Introduction
11.8.4 MBL Life Science Revenue in In Vitro Diagnostic Antibodies Business (2017-2022)
11.8.5 MBL Life Science Recent Developments
11.9 Alpha Diagnostic
11.9.1 Alpha Diagnostic Company Details
11.9.2 Alpha Diagnostic Business Overview
11.9.3 Alpha Diagnostic In Vitro Diagnostic Antibodies Introduction
11.9.4 Alpha Diagnostic Revenue in In Vitro Diagnostic Antibodies Business (2017-2022)
11.9.5 Alpha Diagnostic Recent Developments
11.10 Rekom Biotech SL
11.10.1 Rekom Biotech SL Company Details
11.10.2 Rekom Biotech SL Business Overview
11.10.3 Rekom Biotech SL In Vitro Diagnostic Antibodies Introduction
11.10.4 Rekom Biotech SL Revenue in In Vitro Diagnostic Antibodies Business (2017-2022)
11.10.5 Rekom Biotech SL Recent Developments
11.11 Diasource
11.11.1 Diasource Company Details
11.11.2 Diasource Business Overview
11.11.3 Diasource In Vitro Diagnostic Antibodies Introduction
11.11.4 Diasource Revenue in In Vitro Diagnostic Antibodies Business (2017-2022)
11.11.5 Diasource Recent Developments
11.12 ImmunoReagents
11.12.1 ImmunoReagents Company Details
11.12.2 ImmunoReagents Business Overview
11.12.3 ImmunoReagents In Vitro Diagnostic Antibodies Introduction
11.12.4 ImmunoReagents Revenue in In Vitro Diagnostic Antibodies Business (2017-2022)
11.12.5 ImmunoReagents Recent Developments
11.13 Rapid Novor
11.13.1 Rapid Novor Company Details
11.13.2 Rapid Novor Business Overview
11.13.3 Rapid Novor In Vitro Diagnostic Antibodies Introduction
11.13.4 Rapid Novor Revenue in In Vitro Diagnostic Antibodies Business (2017-2022)
11.13.5 Rapid Novor Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer